Related Experiment Video
Updated: Jan 13, 2026

Stimulation of Cytoplasmic DNA Sensing Pathways In Vitro and In Vivo
Published on: September 18, 2014
Innate immune sensing via the cGAS-STING pathway restricts extrachromosomal DNA-driven tumorigenesis
Tuo Li1,2,3, Qing-Lin Yang1,2,4, Kailiang Qiao4
1Department of Molecular Biology, University of Texas Southwestern Medical Center.
Abstract:
Extrachromosomal DNAs (ecDNAs) are circular DNA fragments frequently found in human cancers, where they amplify oncogenes, drive tumor heterogeneity, and promote therapy resistance and poor prognosis. Despite their prevalence, how ecDNAs interact with the immune system remains poorly understood. Here, we show that the cytosolic DNA sensor cGAS detects ecDNA fragments in the cytoplasm and activates the innate immune response. cGAS and STING are frequently silenced in ecDNA+ tumors through promoter hypermethylation. Restoring cGAS or STING in human and murine ecDNA+ cancer cells reactivates innate immune signaling and selectively suppresses ecDNA+ tumor growth in an immunocompetent mouse model. Using two ecDNA biogenesis models, we show that the cGAS-STING pathway restricts de novo ecDNA formation. Together, our findings identify innate immune sensing as a natural barrier to ecDNA-driven oncogenesis and establish cGAS-STING reactivation as a therapeutic strategy for ecDNA+ cancers.
Insights
Cytosolic DNA sensor cGAS detects extrachromosomal DNA (ecDNA) fragments, activating immunity. Reactivating the cGAS-STING pathway suppresses ecDNA-driven tumors and restricts ecDNA formation, offering a new cancer therapy.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Extrachromosomal DNAs (ecDNAs) are prevalent in human cancers, amplifying oncogenes and driving tumor progression.
- The interaction between ecDNAs and the immune system is not well understood.
- ecDNAs contribute to tumor heterogeneity, therapy resistance, and poor prognosis.
Purpose of the Study:
- To investigate the role of cytosolic DNA sensing in ecDNA-positive tumors.
- To determine if the cGAS-STING pathway impacts ecDNA formation and tumor growth.
- To explore the therapeutic potential of reactivating the cGAS-STING pathway in ecDNA-driven cancers.
Main Methods:
- Detection of ecDNA fragments by the cGAS sensor in the cytoplasm.
- Analysis of cGAS and STING silencing via promoter hypermethylation in ecDNA+ tumors.
- Restoration of cGAS or STING function in human and murine cancer cells.
- Assessment of tumor growth suppression in immunocompetent mouse models.
- Investigation of ecDNA biogenesis using specific models.
Main Results:
- The cGAS-STING pathway is activated by ecDNA fragments in the cytoplasm.
- cGAS and STING are frequently silenced in ecDNA+ tumors.
- Restoring cGAS or STING reactivates innate immune signaling and suppresses ecDNA+ tumor growth.
- The cGAS-STING pathway restricts the formation of new ecDNAs.
Conclusions:
- Innate immune sensing acts as a natural barrier against ecDNA-driven oncogenesis.
- Reactivation of the cGAS-STING pathway is a promising therapeutic strategy for ecDNA+ cancers.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
The Extrinsic Apoptotic Pathway
DNA Damage can Stall the Cell Cycle

